MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
2.040
-0.040 (-1.92%)
Feb 19, 2026, 12:53 PM EST - Market open
MAIA Biotechnology Market Cap
MAIA Biotechnology has a market cap or net worth of $78.06 million as of February 19, 2026. Its market cap has increased by 57.90% in one year.
Market Cap
78.06M
Enterprise Value
69.85M
1-Year Change
57.90%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since the IPO on July 28, 2022, MAIA Biotechnology's market cap has increased from $51.10M to $78.06M, an increase of 52.76%. That is a compound annual growth rate of 12.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 79.59M | 35.95% |
| Dec 31, 2025 | 58.55M | 13.04% |
| Dec 31, 2024 | 51.79M | 161.26% |
| Dec 29, 2023 | 19.82M | -48.40% |
| Dec 30, 2022 | 38.42M | -24.81% |
| Jul 28, 2022 | 51.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 76.69M |
| Seres Therapeutics | 76.62M |
| ImageneBio | 75.62M |
| XBiotech | 74.69M |
| MediciNova | 73.23M |
| Spruce Biosciences | 70.95M |
| Adicet Bio | 69.83M |
| Gain Therapeutics | 69.62M |